GEMC-511687723225623
Awarded to RENWIK BIOINNOVATIONS PRIVATE LIMITED
₹64,800
Products
| Product | Brand / Model | HSN | Quantity | Unit Price | Amount |
|---|---|---|---|---|---|
| DELAMANID | Biosynth / FM72052 | HSN not specified by seller | 1 No | 64,800 | 64,800 |
Loading
Loading…
Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Schedule-1 | BIO CORPORALS | 1 | ₹95,995.40 |
| 2 | Schedule-2 | BIO CORPORALS | 1 | ₹35,430.20 |
| 3 | Schedule-3 | BIO CORPORALS | 1 | ₹1.1 L |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
21 Feb 2025, 12:00 pmClosed
LEVOFLOXACIN
AMMONIUM FORMATE
K2HPO4
N2HPO4
TRIETHYLAMINE
LINEZOLID
BEDAQUILINE FUMARATE
DELAMANID
Shim pack Scepter
Shim pack XR ODS
Shim pack Scepter Phenyl
7457732
GEM/2025/B/5892508
Two Packet Bid
LEVOFLOXACIN
GeM Contract
15 days
Tamil Nadu; Chennai
Group wise evaluation
BOQ
Awarded to RENWIK BIOINNOVATIONS PRIVATE LIMITED
₹64,800
| Product | Brand / Model | HSN | Quantity | Unit Price | Amount |
|---|---|---|---|---|---|
| DELAMANID | Biosynth / FM72052 | HSN not specified by seller | 1 No | 64,800 | 64,800 |
Awarded to RENWIK BIOINNOVATIONS PRIVATE LIMITED
₹85,920
| Product | Brand / Model | HSN | Quantity | Unit Price | Amount |
|---|---|---|---|---|---|
| LINEZOLID | Medchem / HY-10394 | HSN not specified by seller | 2 Nos | 18,960 | 37,920 |
| BEDAQUILINE FUMARATE | Medchem / HY-14881A | HSN not specified by seller | 2 Nos | 24,000 | 48,000 |
Awarded to BIO CORPORALS
₹2.6 L
| Product | Brand / Model | HSN | Quantity | Unit Price | Amount |
|---|---|---|---|---|---|
| LEVOFLOXACIN | SIGMA ALRICH / 1362103-200MG | 29349990 | 2 Nos | 47,997.7 | 95,995.4 |
| AMMONIUM FORMATE | SIGMA ALRICH / 516961-100G | 29151290 | 4 Nos | 8,857.55 | 35,430.2 |
| K2HPO4 | SIGMA ALRICH / P3786-500G | 28352400 | 6 Nos | 17,818.94 | 106,913.64 |
| N2HPO4 | SIGMA ALRICH / 30435-500G | 28352200 | 2 Nos | 5,676.55 | 11,353.1 |
| TRIETHYLAMINE | SIGMA ALRICH / 471283-500ML | 29211990 | 1 No | 6,317.26 | 6,317.26 |
7 documents required · 7 mandatory
3 yrs
₹3
50%
Exempted
3 Jun 2025
31 Jan 2025
21 Feb 2025
| Item No | Item Title | Description | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|---|
| 1 | LEVOFLOXACIN | Please see Schedule 1 in attached pdf | 2 | Nos | [email protected] | 15 |
| 2 | AMMONIUM FORMATE | Please see Schedule 1 in attached pdf | 4 | Nos | [email protected] | 15 |
| 3 | K2HPO4 | Please see Schedule-1 in attached pdf | 6 | Nos | [email protected] | 15 |
| 4 | N2HPO4 | Please see Schedule-1 in attached pdf | 2 | Nos | [email protected] | 15 |
| 5 | TRIETHYLAMINE | Please see Schedule-1 in attached pdf | 1 | No | [email protected] | 15 |
| 6 | LINEZOLID | Please see Schedule-2 in attached pdf | 2 | Nos | [email protected] | 15 |
| 7 | BEDAQUILINE FUMARATE | Please see Schedule-2 in attached pdf | 2 | Nos | [email protected] | 15 |
| 8 | DELAMANID | Please see Schedule-3 in attached pdf | 1 | No | [email protected] | 15 |
| 9 | Shim pack Scepter | Please see Schedule 4 in attached pdf | 1 | No | [email protected] | 15 |
| 10 | Shim pack XR ODS | Please see Schedule 4 in attached pdf | 1 | No | [email protected] | 15 |
contract_GEMC-511687723225623.pdf
GEM_CONTRACT • 0.06 MB
contract_GEMC-511687755385324.pdf
GEM_CONTRACT
contract_GEMC-511687782841826.pdf
GEM_CONTRACT
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_7457732.pdf
GEM_BID
specification_document_-_dr-azger___dr-leeberk_2025-01-31-11-24-14_b394ac58c30aea4c329f68af3be56f2a.pdf
BOQ
boq_-_dr-azger___dr-leeberk_2025-01-31-11-24-14_747fc03b88b0dba0f19c8c5a9d7f38d0.csv
BOQ
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .